The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sesha Sai Nikhil Chintalapati & Others
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sesha Sai Nikhil Chintalapati, classified as a non-promoter, was allotted 48,67,348 equity shares of Astal Laboratories on 14 January 2026 through a preferential allotment under a share swap arrangement. His individual stake jumped from 1.09% to 11.81% of the company, while combined holding with PAC Venkata Ramchandra Murthy Chintalapati rose from 1.12% to 11.82%. The company's total share capital expanded nearly fourfold, from Rs. 10.77 crore (1.07 crore shares) to Rs. 42.22 crore (4.22 crore shares), indicating Astal Labs likely issued these shares as consideration for acquiring another entity. This is a non-promoter entry into the shareholder base at a meaningful size, not an open-market or promoter-led transaction.
Existing shareholders face significant dilution as the share capital expanded roughly 4x to accommodate the share swap. The arrival of an ~11.8% non-promoter stakeholder via a share swap suggests a possible reverse acquisition or strategic transaction — investors should look for details of what assets or shares were exchanged to assess whether this is value-accretive.